Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea [Phase 3]
Phase 3 study comparing GT267-004 to vancomycin and metronidazole for Clostridioides difficile infection with associated diarrhea has comple…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years [Phase 1]
Pfizer conducted a Phase 1 study to evaluate a three-dose vaccination regimen using ascending dose levels of a Clostridioides difficile vacc…
-
CLINICAL_TRIALS research · 2014-03-05Clinical Trial Update: Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region
This is a completed clinical trial update describing the descriptive epidemiology of Clostridioides difficile infection among hospitalized a…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of Cadazolid in patients with Clostridioides difficile infection has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly [Phase 2]
A Phase 2 trial investigating a Lactobacillus acidophilus/Lactobacillus rhamnosus probiotic combination to prevent antibiotic-associated dia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-12-13Clinical Trial Update: Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT) [NA]
A clinical trial investigating fecal microbiota transplantation for Clostridioides difficile infection has been withdrawn.
-
FDA approval · 2013-11-18FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for DIFICID (fidaxomicin) filed by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS withdrawal · 2013-11-11Clinical Trial Update: Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections [Phase 2]
Phase 2 trial evaluating the safety and clinical effectiveness of the oral probiotic MIYA-BM to prevent recurrent Clostridioides difficile i…
-
CLINICAL_TRIALS research · 2013-10-31Clinical Trial Update: Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis [NA]
Clinical trial update on fecal microbiota therapy for recurrent Clostridioides difficile infection, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) [NA]
A completed clinical trial evaluated the pharmacokinetics and safety of tigecycline for treating Clostridioides difficile infection–associat…
-
CLINICAL_TRIALS research · 2013-10-11Clinical Trial Update: Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis [NA]
This document provides an update on a clinical trial investigating fecal microbiota transplantation for recurrent or refractory Clostridioid…
-
CLINICAL_TRIALS research · 2013-10-09Clinical Trial Update: Transplantation of Fecal Microbiota for Clostridium Difficile Infection [Phase 3]
A Phase 3 clinical trial is evaluating fecal microbiota transplantation for Clostridioides difficile infection; the current status is unknow…
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children [Phase 3]
Phase 3 trial evaluating Lactobacillus reuteri to prevent antibiotic-associated diarrhea and Clostridioides difficile infection in hospitali…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis [Phase 2]
Phase 2 safety, tolerability and pharmacokinetic study comparing two metronidazole formulations with immediate-release metronidazole in pati…
-
FDA approval · 2013-06-06FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for DIFICID (fidaxomicin) filed by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea [Phase 2, Phase 3]
Update on Phase 2/Phase 3 trials evaluating probiotics to prevent antibiotic-associated diarrhea and Clostridioides difficile infection; stu…
-
FDA approval · 2013-04-04FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for DIFICID (fidaxomicin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2013-02-21FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for DIFICID (fidaxomicin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Response of Clostridium Difficile Infection to Metronidazole Therapy
This clinical trial update describes the response of Clostridioides difficile infection to metronidazole therapy, with the study status show…
-
FDA approval · 2012-12-19FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for DIFICID (fidaxomicin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS withdrawal · 2012-08-28Clinical Trial Update: Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies [Phase 2, Phase 3]
This clinical trial assessing an oral colostrum-derived anti-Clostridioides difficile antibodies for Clostridioides difficile infection has …
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe [Phase 4]
A Phase 4 clinical trial update from Ascension Health evaluating oral lavage to improve treatment of Clostridioides difficile infection befo…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity [Phase 1]
Sanofi conducted a Phase I randomized, placebo-controlled, double-blind, dose-ranging study in Clostridioides difficile infection and diarrh…
-
FDA approval · 2012-04-09FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original ANDA for vancomycin hydrochloride from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., enabling a g…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers [Phase 1]
Phase 1 trial evaluating safety, tolerability, and immunogenicity of a Clostridioides difficile toxoid vaccine in healthy elderly volunteers…